95 related articles for article (PubMed ID: 18079623)
41. Neoadjuvant chemotherapy with cisplatin, 5-FU, and leucovorin (PLF) in locally advanced gastric cancer: a prospective phase II study.
Ott K; Sendler A; Becker K; Dittler HJ; Helmberger H; Busch R; Kollmannsberger C; Siewert JR; Fink U
Gastric Cancer; 2003; 6(3):159-67. PubMed ID: 14520529
[TBL] [Abstract][Full Text] [Related]
42. CPT-11 and cisplatin in the treatment of advanced gastric cancer in Asians.
Lim WT; Lim ST; Wong NS; Koo WH
J Chemother; 2003 Aug; 15(4):400-5. PubMed ID: 12962370
[TBL] [Abstract][Full Text] [Related]
43. [Combination therapy of a novel oral fluorouracil derivative TS-1 with low-dose cisplatin for recurrent and very advanced gastric cancer].
Nakata B; Hirakawa K
Gan To Kagaku Ryoho; 2004 Nov; 31(12):1962-8. PubMed ID: 15570921
[TBL] [Abstract][Full Text] [Related]
44. Bi-weekly chemotherapy with cisplatin, epirubicin, folinic acid and 5-fluororacil continuous infusion plus g-csf in advanced gastric cancer: a multicentric phase II study.
Felici A; Carlini P; Ruggeri EM; Gamucci T; Pollera CF; De Marco S; Fariello AM; Moscetti L; Gelibter A; Adami E; Sperduti I; Cognetti F
Cancer Chemother Pharmacol; 2006 Jan; 57(1):59-64. PubMed ID: 16001173
[TBL] [Abstract][Full Text] [Related]
45. Weekly infusional high-dose 5-fluorouracil and leucovorin and biweekly cisplatin: a convenient treatment option in advanced gastric cancer.
Kundel Y; Purim O; Figer A; Stemmer SM; Tichler T; Sulkes J; Sulkes A; Brenner B
Med Sci Monit; 2008 Apr; 14(4):CR190-5. PubMed ID: 18376346
[TBL] [Abstract][Full Text] [Related]
46. Irinotecan in the treatment of gastric cancer.
Bugat R
Ann Oncol; 2003; 14 Suppl 2():ii37-40. PubMed ID: 12810456
[TBL] [Abstract][Full Text] [Related]
47. [Irinotecan+cisplatin and irradiation are effective for brain metastases of gastric cancer--two case reports].
Rino Y; Sekino Y; Yamada T; Nakayama T; Arai H; Kanari M; Saeki H; Yukawa N; Wada N; Masuda M; Higashida T; Imada T
Gan To Kagaku Ryoho; 2007 Jul; 34(7):1095-8. PubMed ID: 17637547
[TBL] [Abstract][Full Text] [Related]
48. Phase II study of irinotecan and mitomycin C in 5-fluorouracil-pretreated patients with advanced colorectal and gastric cancer.
Bamias A; Papamichael D; Syrigos K; Pavlidis N
J Chemother; 2003 Jun; 15(3):275-81. PubMed ID: 12868555
[TBL] [Abstract][Full Text] [Related]
49. Two different schedules of irinotecan (CPT-11) in patients with advanced colorectal carcinoma relapsing after a 5-fluorouracil and leucovorin combination. A randomized study.
Tsavaris N; Ziras N; Kosmas C; Giannakakis T; Gouveris P; Vadiaka M; Dimitrakopoulos A; Karadima D; Rokana S; Papalambros E; Papastratis G; Margaris H; Tsipras H; Polyzos A
Cancer Chemother Pharmacol; 2003 Dec; 52(6):514-9. PubMed ID: 14504920
[TBL] [Abstract][Full Text] [Related]
50. Combination chemotherapy of irinotecan plus cisplatin for advanced gastric cancer: efficacy and feasibility in clinical practice.
Yoshida M; Boku N; Ohtsu A; Muto M; Nagashima F; Yoshida S
Gastric Cancer; 2001; 4(3):144-9. PubMed ID: 11760080
[TBL] [Abstract][Full Text] [Related]
51. [Irinotecan (CPT-11) therapy for advanced gastric cancer].
Sakata Y
Nihon Rinsho; 2001 Apr; 59 Suppl 4():386-92. PubMed ID: 11424411
[No Abstract] [Full Text] [Related]
52. [A case of effective weekly paclitaxel administration for metastatic gastric cancer].
Kokufu I; Kimura F; Tanei T; Taniguchi H; Fukuda K; Yamamoto M; Yano T; Yamada K
Gan To Kagaku Ryoho; 2003 Aug; 30(8):1165-8. PubMed ID: 12938275
[TBL] [Abstract][Full Text] [Related]
53. [Basic strategies on first- and second-line chemotherapy for advanced gastric cancers].
Yoshida S
Nihon Shokakibyo Gakkai Zasshi; 2007 Feb; 104(2):171-6. PubMed ID: 17283410
[No Abstract] [Full Text] [Related]
54. [A case of gastric carcinoma with multiple skin, bone, and bilateral ovary metastasis; effective treatment by chemotherapy].
Mezawa S; Homma H; Doi T; Akiyama T; Murakami K; Kogawa K; Hirata K; Kida M; Murase K; Iyama S
Gan To Kagaku Ryoho; 2003 Nov; 30(12):1973-5. PubMed ID: 14650970
[TBL] [Abstract][Full Text] [Related]
55. Meta-analysis of two randomized phase III trials (TCOG GI-0801 and ECRIN TRICS) of biweekly irinotecan plus cisplatin versus irinotecan alone as second-line treatment for advanced gastric cancer.
Nishikawa K; Koizumi W; Tsuburaya A; Yamanaka T; Morita S; Fujitani K; Akamaru Y; Shimada K; Hosaka H; Nakayama N; Tsujinaka T; Sakamoto J
Gastric Cancer; 2020 Jan; 23(1):160-167. PubMed ID: 31309387
[TBL] [Abstract][Full Text] [Related]
56. [Two cases of CPT-11 and CDDP chemotherapy for advanced pancreatic cancer].
Takagi K; Kawamoto K; Itoh T
Gan To Kagaku Ryoho; 2012 May; 39(5):847-9. PubMed ID: 22584347
[TBL] [Abstract][Full Text] [Related]
57. [Evaluation of combination chemotherapy with 5-FU, CDDP and CPT-11 for human gastric carcinoma transplanted into nude mice - comparative study of in vivo chemosensitivity test].
Kanamori N; Fujii M; Kochi M; Kaiga T; Takahashi T; Takayama T
Gan To Kagaku Ryoho; 2007 Jun; 34(6):881-4. PubMed ID: 17565250
[TBL] [Abstract][Full Text] [Related]
58. A phase II multicentre study of irinotecan (CPT 11) in combination with cisplatin (CDDP) in metastatic or locally advanced penile carcinoma (EORTC PROTOCOL 30992).
Theodore C; Skoneczna I; Bodrogi I; Leahy M; Kerst JM; Collette L; Ven K; Marréaud S; Oliver RDT;
Ann Oncol; 2008 Jul; 19(7):1304-1307. PubMed ID: 18417462
[TBL] [Abstract][Full Text] [Related]
59. Irinotecan plus low-dose cisplatin for alpha-fetoprotein-producing gastric carcinoma with multiple liver metastases: report of two cases.
Shimada S; Hayashi N; Marutsuka T; Baba Y; Yokoyama S; Iyama K; Ogawa M
Surg Today; 2002; 32(12):1075-80. PubMed ID: 12541026
[TBL] [Abstract][Full Text] [Related]
60. [Chemotherapy of irinotecan (CPT-11) combined with cisplatin in patients with advanced gastric cancer].
Sato A; Shimada K; Nakamachi M; Wada M; Koda T; Matsukawa M
Nihon Rinsho; 2001 Apr; 59 Suppl 4():375-80. PubMed ID: 11424409
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
